FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.13  |  FHIR Version n/a  User: [n/a]

4685711000001109: Guaifenesin 100mg/5ml / Pseudoephedrine 30mg/5ml oral solution 150 ml (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 01-May 2006. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
21263301000001117 Guaifenesin 100mg/5ml / Pseudoephedrine 30mg/5ml oral solution 150 ml (product) en Fully specified name Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module
21263401000001113 Guaifenesin 100mg/5ml / Pseudoephedrine 30mg/5ml oral solution 150 ml en Synonym Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module

1 descendants. Search Descendants:

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Guaifenesin 100mg/5ml / Pseudoephedrine 30mg/5ml oral solution 150 ml Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Guaifenesin 100mg/5ml / Pseudoephedrine 30mg/5ml oral solution 150 ml Is a Virtual medicinal product pack true Inferred relationship Existential restriction modifier
Guaifenesin 100mg/5ml / Pseudoephedrine 30mg/5ml oral solution 150 ml Is pack of Guaifenesin 100mg/5ml / Pseudoephedrine 30mg/5ml oral solution false Inferred relationship Existential restriction modifier
Guaifenesin 100mg/5ml / Pseudoephedrine 30mg/5ml oral solution 150 ml Has active ingredient Pseudoephedrine hydrochloride false Inferred relationship Existential restriction modifier
Guaifenesin 100mg/5ml / Pseudoephedrine 30mg/5ml oral solution 150 ml Has active ingredient Guaifenesin false Inferred relationship Existential restriction modifier
Guaifenesin 100mg/5ml / Pseudoephedrine 30mg/5ml oral solution 150 ml VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Guaifenesin 100mg/5ml / Pseudoephedrine 30mg/5ml oral solution 150 ml VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Guaifenesin 100mg/5ml / Pseudoephedrine 30mg/5ml oral solution 150 ml Has manufactured dose form Conventional release oral solution false Inferred relationship Existential restriction modifier
Guaifenesin 100mg/5ml / Pseudoephedrine 30mg/5ml oral solution 150 ml Has VMP Guaifenesin 100mg/5ml / Pseudoephedrine 30mg/5ml oral solution true Inferred relationship Existential restriction modifier
Guaifenesin 100mg/5ml / Pseudoephedrine 30mg/5ml oral solution 150 ml Has specific active ingredient Pseudoephedrine hydrochloride true Inferred relationship Existential restriction modifier
Guaifenesin 100mg/5ml / Pseudoephedrine 30mg/5ml oral solution 150 ml Has specific active ingredient Guaifenesin true Inferred relationship Existential restriction modifier
Guaifenesin 100mg/5ml / Pseudoephedrine 30mg/5ml oral solution 150 ml Has dispensed dose form Conventional release oral solution true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Nirolex Chesty Coughs with Decongestant oral solution (The Boots Company) 150 ml Is a True Guaifenesin 100mg/5ml / Pseudoephedrine 30mg/5ml oral solution 150 ml Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start